Enhancement of glucose uptake in mouse skeletal muscle cells and adipocytes by P2Y6 receptor agonists

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Balasubramanian, Ramachandran ^a   Robaye, Bernard ^b   Boeynaems, Jean Marie ^b   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXYGLUCOSE H 3; ADENYLATE KINASE; COMPOUND C; ENZYME INHIBITOR; GLUCOSE TRANSPORTER 4; HISTONE DEACETYLASE 5; INSULIN; N,N' 1,4 BUTANEDIYL BIS[N9 (3 ISOTHIOCYANATOPHENYL)THIOUREA]; P1 (59 URIDINE) P3 (59 N4 METHOXYCYTIDINE)TRIPHOSPHATE; PURINERGIC P2Y RECEPTOR AGONIST; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y6 RECEPTOR; SMALL INTERFERING RNA; TRITIUM; UNCLASSIFIED DRUG; CYTIDINE TRIPHOSPHATE; DINUCLEOSIDE PHOSPHATE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOTHIOCYANIC ACID DERIVATIVE; N,N''-1,4-BUTANEDIYLBIS(N'-(3-ISOTHIOCYANATOPHENYL))THIOUREA; P1-(5'-URIDINE)-P3-(5'-N4-METHOXYCYTIDINE)TRIPHOSPHATE; PURINERGIC P2 RECEPTOR; SLC2A4 PROTEIN, MOUSE; THIOUREA;

3T3 CELL LINE; ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INTRACELLULAR SIGNALING; MOUSE; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

MUS;

3T3-L1 CELLS; ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CYTIDINE TRIPHOSPHATE; DINUCLEOSIDE PHOSPHATES; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; ISOTHIOCYANATES; MICE; MUSCLE FIBERS, SKELETAL; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; THIOUREA;

EID: 84920188116     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116203     Document Type: Article

References (42)

1. Schwartz MW, Seeley RJ, Tschop MH, Woods SC, Morton GJ, et al. (2013) Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 503: 59-66.
2. Burnstock G, Verkhratsky A (2012) Purinergic signaling. WIREs Membr Transp Signal 1: 116-125. http://dx.doi.org/10.1002/wmts.14.
3. 6 receptor. Biochem Biophys Res Commun 222: 303-308.
4. Moore DJ, Chambers JK, Wahlin JP, Tan KB, Moore GB, et al. (2001) Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study. Biochim Biophys Acta 1521: 107-119.
5. 6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis. Cell Mol Neurobiol 23: 401-418.
6. 6 receptor activation. Pharmacol Res 58: 232-239.
7. 6 receptor-induced secretion in MIN6 mouse pancreatic β cells. Biochem Pharmacol 85: 991-998.
8. 6 receptors. Biochem Biophys Res Commun 370: 499-503.
9. Sassmann A, Gier B, Gröne HJ, Drews G, Offermanns S, et al. (2010) The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice. J Clin Invest 120: 2184-2193.
10. 13 receptors in mice. Diabetologia 53: 1927-1934.
11. 6 nucleotide receptors. Biochem Pharmacol 67: 1763-1770.
12. 6 receptor agonists: Novel 4-alkyloxyimino, (S)-methanocarba, and 5′-triphosphate γ-ester modifications. J Med Chem 53: 4488-4501.
13. 6 Receptors. J Med Chem 54: 2878-2890.
14. 6-receptor agonist. J Med Chem 53: 1673-1685.
15. 3-muscarinic acetylcholine receptor stimulates glucose uptake in L6 skeletal muscle cells by a CaMKK-AMPK-dependent mechanism. Cell Signal 22: 1104-1113.
16. Song XM, Fiedler M, Galuska D, Ryder JW, Fernström M, et al. (2002) 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 45: 56-65.
17. Koistinen HA, Galuska D, Chibalin AV, Yang J, Zierath JR, et al. (2003) 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52: 1066-1072.
18. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW (1999) 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671.
19. Rachdaoui N, Nagy LE (2003) Endothelin-1-stimulated glucose uptake is desensitized by tumor necrosis factor-alpha in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 285: E545-E551.
20. Karczewska J, Piwkowska A, Rogacka D, Ste¸piński J, Angielski S, et al. (2011) Purinergic modulation of glucose uptake into cultured rat podocytes: effect of diabetic milieu. Biochem Biophys Res Commun 404: 723-727.
21. Olson AL, Pessin JE (1996) Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annual Rev Nutr 16: 235-256.
22. McGee SL, van Denderen BJ, Howlett KF, Mollica J, Schertzer JD, et al. (2008). AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating Histone deacetylase 5. Diabetes 57: 860-867.
23. Vieira RP, Müller T, Grimm M, von Gernler V, Vetter B, et al. (2011) Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation. Am J Respir Crit Care Med 184: 215-223.
24. 6 nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 276: 26051-26056.
25. 6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol 74: 777-784.
26. Guns PJ, Hendrickx J, Van Assche T, Fransen P, Bult H (2010) P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice. Br J Pharmacol 159: 326-336.
27. Weems JC, Griesel BA, Olson AL (2012) Class II histone deacetylase downregulate GLUT4 transcription in response to increased cAMP signaling in cultured adipocytes and fasting mice. Diabetes 61: 1401-1414.
28. Sparling DP, Griesel BA, Weems JC, Olson AL (2008) GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes. J Biol Chem 283: 7429-7437.
29. Murgia M, Jensen TE, Cusinato M, Garcia M, Richter EA, et al. (2009) Multiple signaling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle. J Physiol 587: 4319-4327.
30. Mukwevho E, Kohn TA, Lang D, Nyatia E, Smith J, et al. (2008) Caffeine induces hyperacetylation of histones at the MEF2 site on the Glut4 promoter and increases MEF2A binding to the site via a CaMK-dependent mechanism. Am J Physiol Endocrinol Metab 294: E582-E588.
31. Christensen DP, Dahllöf M, Lundh M, Rasmussen DN, Nielsen MD, et al. (2011) Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Med 17: 378-390.
32. 2 receptor activity as glycemic agents. PCT Int Appl, WO 2006052007 A1 20060518.
33. Solini A, Chiozzi P, Morelli A, Passaro A, Fellin R, et al. (2003) Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport. J Cell Physiol 197: 435-444.
34. Thaning P, Bune LT, Hellsten Y, Pilegaard H, Saltin B, et al. (2010) Attenuated purinergic receptor function in patients with type 2 diabetes. Diabetes 59: 182-189.
35. +-glucose cotransporter activity via cAMP and p38 MAPK in renal proximal tubule cells. Am J Physiol 289: C1268-C1276.
36. q-coupled receptor improves β-cell function. J Clin Invest 123: 1750-1762.
37. q-coupled receptor in hepatocytes in vivo. Endocrinology 154: 3539-3551.
38. Ruan H, Zarnowski MJ, Cushman SW, Lodish HF (2003) Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 278: 47585-47593.
39. Aune UL, Ruiz L, Kajimura S (2013) Isolation and differentiation of stromal vascular cells to beige/brite cells. J Vis Exp Mar 26 (73) doi: 10.3791/50191.
40. Shibata H, Omata W, Suzuki Y, Tanaka S, Kojima I (1996) A synthetic peptide corresponding to the Rab4 hypervariable carboxyl-terminal domain inhibits insulin action on glucose transport in rat adipocytes. J Biol Chem 271: 9704-9709.
41. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
42. Gong H, Xie J, Zhang N, Yao L, Zhang Y (2011) MEF2A binding to the Glut4 promoter occurs via an AMPKα2-dependent mechanism. Med Sci Sports Exerc 43: 1441-1450.